DGIdb - CYPROTERONE Drug Record

CYPROTERONE chembl:CHEMBL142130

Alternate Names:

CYPROTERONE

Drug Info:

FDA Approval	Approved before 1982
Drug Class	small molecule
Drug Indications	Antihirsutism agents
Drug Indications	Hypersexuality-inhibiting agents
Drug Class	antihirsutism agents
Drug Class	hypersexuality-inhibiting agents
Year of Approval	approved before 1982

(2 More Sources)

Publications:

Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol

CYPROTERONE NR1I2

Interaction Score: 0.08

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
CYPROTERONE CYP2C9

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
CYPROTERONE AR

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
None found

Sources:
DTC TdgClinicalTrial TEND TTD
CYPROTERONE CYP2C19

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
CYPROTERONE CYP1A2

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
CYPROTERONE CYP2D6

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
CYPROTERONE CYP3A4

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC

TEND: CYPROTERONE
- Version: 01-August-2011
Alternate Names:

CYPROTERONE Primary Drug Name

Drug Info:

Year of Approval approved before 1982

Drug Class hypersexuality-inhibiting agents

Drug Class antihirsutism agents

Publications:
TdgClinicalTrial: CYPROTERONE
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications Hypersexuality-inhibiting agents

Drug Indications Antihirsutism agents

Drug Class small molecule

Publications:
DTC: CYPROTERONE
- Version: 02-September-2020
Alternate Names:

CHEMBL142130 ChEMBL Drug ID

Drug Info:

Publications:

Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol
TTD: Cyproterone
- Version: 2020.06.01
Alternate Names:

D06AEO TTD Drug ID

Drug Info:

Publications:
ChemblDrugs: chembl:CHEMBL142130
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:
PharmGKB: cyproterone
- Version: 18-August-2020
Alternate Names:

Drug Info:

Publications:

Trial Name	-
Novel drug target	Established target

CYPROTERONE Drug Record

CYPROTERONE chembl:CHEMBL142130

Alternate Names:

Drug Info:

Publications:

CYPROTERONE NR1I2

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: PharmGKB

CYPROTERONE CYP2C9

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22931300

Sources: DTC

CYPROTERONE AR

Interaction Types & Directionality: n/a

Interaction Info: Trial Name - Novel drug target Established target

PMIDs: None found

Sources: DTC TdgClinicalTrial TEND TTD

CYPROTERONE CYP2C19

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22931300

Sources: DTC

CYPROTERONE CYP1A2

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22931300

Sources: DTC

CYPROTERONE CYP2D6

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22931300

Sources: DTC

CYPROTERONE CYP3A4

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22931300

Sources: DTC

TEND: CYPROTERONE

Alternate Names: CYPROTERONE Primary Drug Name

Drug Info: Year of Approval approved before 1982 Drug Class hypersexuality-inhibiting agents Drug Class antihirsutism agents

Publications:

TdgClinicalTrial: CYPROTERONE

Alternate Names:

Drug Info: Drug Indications Hypersexuality-inhibiting agents Drug Indications Antihirsutism agents Drug Class small molecule

Publications:

DTC: CYPROTERONE

Alternate Names: CHEMBL142130 ChEMBL Drug ID

Drug Info:

Publications: Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for &gt;200 compounds., Chem Res Toxicol

TTD: Cyproterone

Alternate Names: D06AEO TTD Drug ID

Drug Info:

Publications:

ChemblDrugs: chembl:CHEMBL142130

Alternate Names:

Drug Info:

Publications:

PharmGKB: cyproterone

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
22931300

Sources:
DTC

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
None found

Sources:
DTC TdgClinicalTrial TEND TTD

Interaction Types & Directionality:

n/a

PMIDs:
22931300

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
22931300

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
22931300

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
22931300

Sources:
DTC

Alternate Names:

CYPROTERONE Primary Drug Name

Drug Info:

Year of Approval approved before 1982

Drug Class hypersexuality-inhibiting agents

Drug Class antihirsutism agents

Drug Info:

Drug Indications Hypersexuality-inhibiting agents

Drug Indications Antihirsutism agents

Drug Class small molecule

Alternate Names:

CHEMBL142130 ChEMBL Drug ID

Publications:

Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol

Alternate Names:

D06AEO TTD Drug ID